Estrogen cream is a topical hormone treatment applied inside the vagina to restore moisture, relieve irritation, and reverse tissue thinning caused by declining estrogen levels. It’s one of the most common treatments for the collection of vaginal and urinary symptoms that develop during and after menopause, and it works by delivering estrogen directly where it’s needed rather than flooding the entire body.
What Estrogen Cream Treats
When estrogen levels drop during menopause, the vaginal walls thin out, lose elasticity, and produce less natural lubrication. This process, called vaginal atrophy, is part of a broader set of changes now referred to as genitourinary syndrome of menopause. It can cause vaginal dryness, itching, burning, and pain during sex. It also affects the urinary tract, leading to frequent urination, a sudden urgent need to go, burning during urination, and recurrent urinary tract infections.
These symptoms affect the majority of postmenopausal women and, unlike hot flashes, tend to get worse over time rather than better. Estrogen cream addresses the root cause by replenishing the hormone locally. For a single symptom like dryness, non-hormonal moisturizers or lubricants can be a reasonable first step. But when multiple symptoms are present, clinical guidelines recommend vaginal estrogen over non-hormonal options because it treats the underlying tissue changes rather than just masking them.
How It Works in the Body
Vaginal estrogen cream delivers the hormone directly to the vaginal lining, where it stimulates the growth of new surface cells and essentially re-thickens tissue that had thinned from low estrogen. This process restores moisture, improves blood flow, and helps the vaginal environment return to a healthier, more acidic state that naturally resists infection.
The key advantage over oral estrogen is minimal systemic absorption. When you take estrogen by mouth, it passes through the liver before reaching the rest of the body, which raises blood levels of estrogen significantly. Vaginal creams bypass the liver entirely. Published data show that low-dose vaginal estrogens raise blood estrogen levels only minimally, well below what oral or patch-based estrogen produces. This is why vaginal estrogen is considered a different category of treatment from systemic hormone therapy.
Available Formulations
Two main types of estrogen cream are FDA-approved:
- Estrace: contains estradiol, the form of estrogen your body naturally produces in the highest amounts before menopause.
- Premarin: contains conjugated estrogens, which are derived from multiple estrogen compounds. It’s also approved for a condition called kraurosis vulvae, which causes vulvar dryness and discomfort in women of any age, not just those in menopause.
Vaginal estrogen also comes in other forms beyond cream, including small tablets (Vagifem), soft inserts (Imvexxy), and flexible rings (Estring, Femring). These all deliver estrogen locally but differ in how you use them and how often. Creams require manual application with an applicator, while rings sit in the vagina for about 90 days before being replaced. Your preference for one format over another often comes down to convenience and comfort.
How to Use It
The typical pattern is the same across most vaginal estrogen products: a loading phase followed by a lower maintenance schedule. You start by using the cream daily for about two weeks, which primes the vaginal tissue and begins rebuilding the thinned lining. After that, you switch to using it just twice a week, every three to four days. Most providers recommend applying it at bedtime so the cream stays in contact with the tissue longer.
For creams specifically, you use a measured applicator to place the medication inside the vagina. Each dose requires a new applicator or a thoroughly cleaned reusable one, depending on the product. The amount applied is small, typically measured in fractions of a gram.
When You’ll Notice a Difference
Estrogen cream doesn’t work overnight. It takes at least two weeks of daily use to begin priming the vaginal lining, and most women notice meaningful improvement in symptoms around four to six weeks. In clinical studies, significant relief in dryness, pain during sex, and urinary symptoms was documented by four weeks, with continued improvement through 12 weeks of therapy. Patience during the first couple of weeks is normal, and stopping early because it doesn’t seem to be working yet is a common but unnecessary reason people abandon treatment.
Protection Against Recurrent UTIs
One of the most practical benefits of vaginal estrogen is its ability to reduce urinary tract infections. Recurrent UTIs are extremely common in postmenopausal women because the loss of estrogen changes the vaginal microbiome, making it easier for harmful bacteria to colonize near the urethra. Vaginal estrogen restores that protective microbial environment.
Multiple randomized controlled trials have shown that vaginal estrogen decreases both the number of UTIs and the time between recurrences. The evidence is strong enough that the American Urological Association’s 2019 guidelines specifically recommend offering vaginal estrogen to peri- and postmenopausal women with recurrent UTIs to lower their risk. For women who have been cycling through repeated antibiotic courses, this can be a meaningful change in approach.
Safety and Long-Term Use
The safety profile of low-dose vaginal estrogen is reassuring. A follow-up study spanning over six years found no significant increases in stroke, invasive breast cancer, endometrial cancer, colorectal cancer, or blood clots associated with local estrogen use. This is a critical distinction from systemic hormone therapy, which does carry measurable risks for some of these conditions.
Because systemic absorption is so low, routine monitoring of the uterine lining through ultrasound or biopsy is unnecessary for most women using standard doses. Long-term use is considered safe, and maintenance therapy can continue beyond the point where symptoms resolve, since stopping often means symptoms return as the tissue thins again. Any unexpected vaginal bleeding, however, should be evaluated promptly.
Current clinical guidelines from menopause societies around the world recommend low-dose vaginal estrogen as the preferred treatment for genitourinary syndrome of menopause, favoring it over systemic hormone therapy when vaginal and urinary symptoms are the primary concern.
Estrogen Cream After Breast Cancer
The one area where estrogen cream use gets more complicated is in women with a history of hormone-sensitive breast cancer. Systemic estrogen is generally considered off-limits for these women because it could theoretically increase recurrence risk. Vaginal estrogen occupies a gray zone: its systemic absorption is very low, but it isn’t zero, which creates uncertainty. The American College of Obstetricians and Gynecologists acknowledges that many women with bothersome symptoms go untreated because of this concern, with real consequences for quality of life. If you have a history of hormone-sensitive cancer, this is a conversation that requires weighing individual risks and benefits with an oncologist and gynecologist together.